Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cullen

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 12, 2017
Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening programH Ansari, D E Beaton, R Sujic, et al.
Clinical and Experimental Pharmacology & Physiology|January 1, 1992
Chemical design of peripherally acting compoundsW R Jackson, F C Copp, J D Cullen, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2008
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitorsMatthew D Cullen, York-Fong Cheung, Miles D Houslay, et al.
Annals of Emergency Medicine|March 17, 2020
PROM-ED: Development and Testing of a Patient-Reported Outcome Measure for Emergency Department Patients Who Are Discharged HomeSamuel Vaillancourt, John D Cullen, Katie N Dainty, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 4, 2021
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitizationUpasana Ray, Debarshi Roy, Ling Jin, et al.
AJOG Global Reports|July 18, 2025
A descriptive analysis of a fertility services waitlist in Eastern CanadaHannah M Murphy, Bailey P S Cox, Heather M Manning, et al.
Journal of Medicinal Chemistry|September 25, 2009
Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptaseMatthew D Cullen, William C Ho, Joseph D Bauman, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 13, 2017
Use of a High-Throughput Phenotypic Screening Strategy to Identify Amplifiers, a Novel Pharmacological Class of Small Molecules That Exhibit Functional Synergy with Potentiators and CorrectorsKenneth A Giuliano, Shinichiro Wachi, Lawrence Drew, et al.
Dermatology (Basel, Switzerland)|August 18, 2011
Necrosis of ears after use of cocaine probably adulterated with levamisoleI de la Hera, V Sanz, D Cullen, et al.
Human Mutation|May 22, 2019
Disease-associated missense variants in ZBTB18 disrupt DNA binding and impair the development of neurons within the embryonic cerebral cortexIsabel A Hemming, Olivier Clément, Ivan E Gladwyn-Ng, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 12, 2017
Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening programH Ansari, D E Beaton, R Sujic, et al.
Clinical and Experimental Pharmacology & Physiology|January 1, 1992
Chemical design of peripherally acting compoundsW R Jackson, F C Copp, J D Cullen, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2008
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitorsMatthew D Cullen, York-Fong Cheung, Miles D Houslay, et al.
Annals of Emergency Medicine|March 17, 2020
PROM-ED: Development and Testing of a Patient-Reported Outcome Measure for Emergency Department Patients Who Are Discharged HomeSamuel Vaillancourt, John D Cullen, Katie N Dainty, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 4, 2021
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitizationUpasana Ray, Debarshi Roy, Ling Jin, et al.
AJOG Global Reports|July 18, 2025
A descriptive analysis of a fertility services waitlist in Eastern CanadaHannah M Murphy, Bailey P S Cox, Heather M Manning, et al.
Journal of Medicinal Chemistry|September 25, 2009
Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptaseMatthew D Cullen, William C Ho, Joseph D Bauman, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 13, 2017
Use of a High-Throughput Phenotypic Screening Strategy to Identify Amplifiers, a Novel Pharmacological Class of Small Molecules That Exhibit Functional Synergy with Potentiators and CorrectorsKenneth A Giuliano, Shinichiro Wachi, Lawrence Drew, et al.
Dermatology (Basel, Switzerland)|August 18, 2011
Necrosis of ears after use of cocaine probably adulterated with levamisoleI de la Hera, V Sanz, D Cullen, et al.
Human Mutation|May 22, 2019
Disease-associated missense variants in ZBTB18 disrupt DNA binding and impair the development of neurons within the embryonic cerebral cortexIsabel A Hemming, Olivier Clément, Ivan E Gladwyn-Ng, et al.
Pageof 15